Paper Details

  1. Home
  2. Paper Details

Dissecting the Yale-Brown Obsessive-Compulsive Scale severity scale to understand the routes for symptomatic improvement in obsessive-compulsive disorder.

Author: BarbosaVeronica S, CostaDaniel L da Conceição, DinizJuliana B, PereiraCarlos A de Bragança, RequenaGuaraci, ShavittRoseli G

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study examined how different aspects of obsessive-compulsive disorder (OCD) symptoms improved with the medication fluoxetine. It found that reductions in distress and increased control over symptoms occurred before improvements in the time spent on obsessions and compulsions or how much they interfered with daily life. This suggests that fluoxetine first helps reduce distress and increase control before addressing the amount of time and interference caused by OCD symptoms.
Paper Details　
Original Abstract of the Article :
We aimed to investigate which items of the Yale-Brown Obsessive-Compulsive Severity Scale best discriminate the reduction in total scores in obsessive-compulsive disorder patients after 4 and 12 weeks of pharmacological treatment. Data from 112 obsessive-compulsive disorder patients who received flu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/0269881117705087

データ提供：米国国立医学図書館（NLM）

Dissecting the Yale-Brown Obsessive-Compulsive Scale severity scale to understand the routes for symptomatic improvement in obsessive-compulsive disorder

Obsessive-compulsive disorder (OCD), a mental health condition characterized by intrusive thoughts and repetitive behaviors, can significantly impact daily life. This study explores the specific aspects of OCD that improve with pharmacological treatment, using the Yale-Brown Obsessive-Compulsive Severity Scale (Y-BOCS) to measure symptom severity.

Understanding the Pathways of Improvement in OCD: A Detailed Analysis

The study found that improvement in OCD symptoms following treatment with fluoxetine was associated with reductions in distress and increases in control over symptoms, before affecting the time spent on or interference from obsessions and compulsions. These findings provide valuable insights into the mechanisms of action of fluoxetine and may help guide treatment strategies for OCD.

Optimizing OCD Treatment: A Targeted Approach

This research underscores the importance of understanding the specific pathways of improvement in OCD. By dissecting the Y-BOCS and identifying key areas of symptom change, clinicians can tailor treatment strategies to target specific aspects of the disorder, potentially improving outcomes and accelerating recovery. This study encourages a more targeted approach to OCD treatment, focusing on specific symptom domains rather than a general reduction in severity.

Dr. Camel's Conclusion

Obsessive-compulsive disorder can be a relentless condition, but research is continually uncovering new insights into its treatment. This study sheds light on the specific ways in which fluoxetine, a common medication for OCD, can improve symptoms. As a camel who has navigated many mental sandstorms, I appreciate the importance of finding the right tools to manage challenging conditions. This research offers hope for a future where OCD can be effectively treated and managed, allowing individuals to live fulfilling lives.

Date :
  1. Date Completed 2018-05-31
  2. Date Revised 2018-10-21
Further Info :

Pubmed ID

28441896

DOI: Digital Object Identifier

10.1177/0269881117705087

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.